Article references (19 references )


  1. Albo D, Wayne JD, Hunt KK, Rahlfs TF et al. Anaphylactic reactions to isosulfan blue dye during sentinel lymph node biopsy for breast cancer. Am J Surg. 2001; 182(4): 393-398. PubMed | Google Scholar

  2. Salvat J Le curage axillaire en 1998 in Bolla M, Vincent F. Du dépistage au diagnostic précoce: le cancer du sein aujourd'hui, Diagnostic, pronostic, traitement. Vélizy, Arnette Inititatives santé. 1998; 195-204.

  3. Dewachter P, Mouton-Faivre C, Benhaijoub A et al. Anaphylactic reaction to patent blue V after sentinel lymph node biopsy. Acta Anaesthesiol. 2006; 50(2): 245-247. PubMed | Google Scholar

  4. Giuliano AE, Kirgan DM, Guenther JM. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg. 1994 Sep; 220(3): 391-8. PubMed

  5. King TA, Fey JV, Van Zee KJ et al. A prospective analysis of the effect of blue-dye volume on sentinel lymph node mapping success and incidence of allergic reaction in patients with breast cancer. Ann SurgOncol. 2004; 11(5): 535-541. PubMed | Google Scholar

  6. Mansouri R, Chicken DW, Keshtgar MR. Allergic reactions to patent blue dye. Surg Oncol. 2006; 15(1): 58. PubMed | Google Scholar

  7. Beenen E, de Roy van Zuidewijn DB. Patients blue on patent blue: an adverse reaction during four sentinel node procedures. Surg Oncol. 2005; 14(4): 151-154. PubMed | Google Scholar

  8. Leong SP, Donegan E, Heffernon W et al. Adverse reactions to isosulfan blue during selective sentinel lymph node dissection in melanoma. Ann Surg Oncol. 2000; 7(7): 361-366. PubMed | Google Scholar

  9. Raut CP, Hunt KK, Akins JS et al. Incidence of anaphylactoid reactions to isosulfan blue dye during breast carcinoma lymphatic mapping in patients treated with preoperative prophylaxis: results of a surgical prospective clinical practice protocol. Cancer. 2005; 104(4): 692-699. PubMed | Google Scholar

  10. Teske HJ, Lenz W, Katsilleris I. Allergy to patent blue: lymphangiography with dye. Rontgenblatter. 1978; 31(11): 636-8. PubMed | Google Scholar

  11. Rosenhall. Evaluation of intolerance to analgesic, preservatives and food colorants with challenge test. Eur J Respir Dis. 1982; 63(5): 410-9. PubMed | Google Scholar

  12. Veronesi U, Paganelli G, Galimberti V. Sentinel node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph nodes. Lancet. 1997 Jun 28; 349(9069): 1864-7. PubMed | Google Scholar

  13. Albertini JJ, Lyman GH, Cox L. Lymphatic mapping and sentinel node biopsy in patients with breast cancer. Jama. 1996 Dec 11; 276(22): 1818-22. PubMed | Google Scholar

  14. Montgomery LL, Thorne AC, Van Zee KJ et al. Isosulfan blue dye reactions during sentinel lymph node mapping for breast cancer. Anesth Analg. 2002; 95(2): 385-388. PubMed | Google Scholar

  15. Thevarajah S, Huston TL, Simmons RM. A comparison of the adverse reactions associated with isosulfan blue versus methylene blue dye in sentinel lymph node biopsy for breast cancer. Am J Surg. 2005; 189(2): 236-239. PubMed | Google Scholar

  16. Laurie SA, Khan DA, Gruchalla RS et al. Anaphylaxis to isosulfan blue. Ann Allergy Asthma Immunol. 2002; 88(1): 64-66. PubMed | Google Scholar

  17. Barthelmes L, Goyal A, Newcombe RG. Adverse reactions to patent blue V dye: the NEW START and ALMANAC experience. Eur J Surg Oncol. 2010; (36). PubMed | Google Scholar

  18. GoyalA, RG Newcombe A, Chhabra RE et al. Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer-results of the ALMANAC validation phase. Breast Cancer Res Treat. 2006 Sep; 99(2): 203-8 PubMed | Google Scholar

  19. Lafourcade MP, Martin M. Anaphylactic shock in surgery due to patent blue. Revue française d'allergologie et d'immunologie clinique. 2008; 48: 459-461.